Literature DB >> 25419679

Disproportionate rise in Clostridium difficile-associated hospitalizations among US youth with inflammatory bowel disease, 1997-2011.

Kelly C Sandberg1, Matthew M Davis, Achamyeleh Gebremariam, Jeremy Adler.   

Abstract

OBJECTIVES: Our aim was to characterize the temporal changes in burden that Clostridium difficile infection (CDI) added to the hospital care of children and young adults with inflammatory bowel disease (IBD) in the United States.
METHODS: Retrospective analysis of annual, nationally representative samples of children and young adults with IBD.
RESULTS: There was a 5-fold increase in IBD hospitalizations with CDI from 1997 to 2011 (P for trend <0.01). During the same period, IBD hospitalizations without CDI increased 2-fold (P for trend <0.01). Mean length of stay for IBD hospitalizations with CDI was consistently longer than that for hospitalizations without CDI and did not significantly change over time (P for trend = 0.47). CDI-related total hospital days in the United States rose from 1702 to 10,194 days per million individuals per year from 1997 to 2011 (P for trend <0.01). Children and young adults hospitalized with CDI had a significantly lower odds of colectomy (0.31) compared with those without CDI. Total charges for CDI-related hospitalizations among children and young adults in the United States rose from $8.7 million in 1997 to $68.2 million in 2011.
CONCLUSIONS: A widening gap in burden has opened between IBD hospitalizations with and without CDI during the last decade and a half. CDI-related hospitalizations are associated with disproportionately longer lengths of stay, more hospital days, and more charges than hospitalizations without CDI over time. Further work within health systems, hospitals, and practices can help us better understand this enlarging gap to improve clinical care for this vulnerable population.

Entities:  

Mesh:

Year:  2015        PMID: 25419679      PMCID: PMC4380677          DOI: 10.1097/MPG.0000000000000636

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  45 in total

1.  Trends in hospitalizations of children with inflammatory bowel disease within the United States from 2000 to 2009.

Authors:  Chaitanya Pant; Michael P Anderson; Abhishek Deshpande; John E Grunow; Judith A O'Connor; Jessica R Philpott; Thomas J Sferra
Journal:  J Investig Med       Date:  2013-08       Impact factor: 2.895

2.  Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence.

Authors:  Abhishek Deshpande; Chaitanya Pant; Michael P Anderson; Curtis J Donskey; Thomas J Sferra
Journal:  Pediatr Infect Dis J       Date:  2013-10       Impact factor: 2.129

3.  Clostridium difficile infection in hospitalized children in the United States.

Authors:  Cade M Nylund; Anthony Goudie; Jose M Garza; Gerry Fairbrother; Mitchell B Cohen
Journal:  Arch Pediatr Adolesc Med       Date:  2011-01-03

4.  Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2010-09-07       Impact factor: 5.325

5.  Nontherapeutic use of antimicrobial agents in animal agriculture: implications for pediatrics.

Authors:  Katherine M Shea
Journal:  Pediatrics       Date:  2004-09       Impact factor: 7.124

6.  Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley; David G Binion
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

Review 7.  Acid suppression and the risk of Clostridium difficile infection.

Authors:  Ethan A Mezoff; Mitchell B Cohen
Journal:  J Pediatr       Date:  2013-06-05       Impact factor: 4.406

8.  Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea.

Authors:  Yogesh M Shastri; Dominik Bergis; Nada Povse; Volker Schäfer; Sarika Shastri; Martin Weindel; Hans Ackermann; Jürgen Stein
Journal:  Am J Med       Date:  2008-12       Impact factor: 4.965

9.  Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection.

Authors:  Daniela Jodorkovsky; Yuki Young; Maria T Abreu
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

10.  Fecal calprotectin and clinical disease activity in pediatric ulcerative colitis.

Authors:  Kaija-Leena Kolho; Dan Turner
Journal:  ISRN Gastroenterol       Date:  2013-02-26
View more
  7 in total

1.  Infection with Toxin A-Negative, Toxin B-Negative, Binary Toxin-Positive Clostridium difficile in a Young Patient with Ulcerative Colitis.

Authors:  Grace O Androga; Julie Hart; Niki F Foster; Adrian Charles; David Forbes; Thomas V Riley
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

Review 2.  Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis.

Authors:  Sheng-Bo Fang; Yan-Qing Song; Chun-Yan Zhang; Li-Bo Wang
Journal:  World J Pediatr       Date:  2021-11-20       Impact factor: 2.764

3.  Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn's Disease.

Authors:  Jennifer Hellmann; Heidi Andersen; Lin Fei; Aaron Linn; Ramona Bezold; Kathleen Lake; Kimberly Jackson; Danielle Meyer; Kelsie Dirksing; Erin Bonkowski; Nicholas J Ollberding; David B Haslam; Lee Denson
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 7.290

4.  Multi-omic Analysis of the Interaction between Clostridioides difficile Infection and Pediatric Inflammatory Bowel Disease.

Authors:  Frederic D Bushman; Maire Conrad; Yue Ren; Chunyu Zhao; Christopher Gu; Christopher Petucci; Min-Soo Kim; Arwa Abbas; Kevin J Downes; Nina Devas; Lisa M Mattei; Jessica Breton; Judith Kelsen; Sarah Marakos; Alissa Galgano; Kelly Kachelries; Jessi Erlichman; Jessica L Hart; Michael Moraskie; Dorothy Kim; Huanjia Zhang; Casey E Hofstaedter; Gary D Wu; James D Lewis; Joseph P Zackular; Hongzhe Li; Kyle Bittinger; Robert Baldassano
Journal:  Cell Host Microbe       Date:  2020-08-20       Impact factor: 31.316

Review 5.  Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.

Authors:  Suchitra K Hourigan; Cynthia L Sears; Maria Oliva-Hemker
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

Review 6.  Management of inflammatory bowel disease with Clostridium difficile infection.

Authors:  Julie D'Aoust; Robert Battat; Talat Bessissow
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

7.  Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease: A Clinician's Dilemma.

Authors:  Máire A Conrad; Judith R Kelsen
Journal:  J Pediatric Infect Dis Soc       Date:  2021-11-17       Impact factor: 5.235

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.